기준가
$37.06
운용 규모
$81.8M
보수율
-
배당수익률
0.89%
베타
0.63
통화
USD
| YTD | 1개월 | 3개월 | 1년 | 3년 | 5년 |
|---|---|---|---|---|---|
| +3.03% | +5.91% | +3.17% | +16.41% | +11.47% | +4.62% |
| 순위 | 종목코드 | 종목명 | 비중 |
|---|---|---|---|
| 1 | NOVO-B.CO | Novo Nordisk AS Class B | 3.80% |
| 2 | LLY | Eli Lilly and Co | 3.59% |
| 3 | EW | Edwards Lifesciences Corp | 3.38% |
| 4 | RO | Roche Holding AG Bearer Shares | 3.22% |
| 5 | ABBV | AbbVie Inc | 3.17% |
| 6 | WELL | Welltower Inc | 3.07% |
| 7 | VTR | Ventas Inc | 3.07% |
| 8 | MRK | Merck & Co Inc | 3.00% |
| 9 | BMY | Bristol-Myers Squibb Co | 2.98% |
| 10 | AMGN | Amgen Inc | 2.94% |
The fund invests more than 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies in developed markets that facilitate the demographic trend of longer average life spans and the aging of the global population, including but not limited to companies involved in biotechnology, medical devices, pharmaceuticals, senior living facilities and specialized health care services.
설정일: 2016-05-09